Spectralytics Adds To $22M IP Verdict Against Cordis

Law360, San Diego (December 1, 2011, 7:07 PM EST) -- A Minnesota federal court on Wednesday ordered Cordis Corp. and stent manufacturer Norman Noble Inc. to pay $500,000 in enhanced damages on top of a $22 million verdict against them for willfully infringing Spectralytics Inc.’s patent covering a stent-cutting machine.

Spectralytics asked the court to increase the damages amount up to three times and sought more than $4 million in attorneys’ fees, but U.S. District Judge Patrick Schiltz declined to award any attorneys’ fees and determined that while the $500,000 amount was small compared to Johnson...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.